With straightforward mechanism of action, alphalex provides an elegant approach to tumor-targeted anti-cancer agents.
Anxiety & depression
Nausea & vomiting
Diarrhea / constipation
Abdominal pain / cramping
Muscle wasting / fatigue
Deep vein thrombosis
Reduce the toxicity of systemic cancer treatments and increase the therapeutic index with targeted intracellular delivery of powerful anticancer agents.
As a tumor selective platform, alphalex can enable new therapeutic uses across different classes of small molecules, unlocking new and better cancer therapeutics and bringing new options to patients.
We’re expanding the population of treatable patients through novel combinations of DDR inhibitor therapies with DNA damaging molecules.See What’s in Our Pipeline